<?xml version="1.0" encoding="UTF-8"?><measure><measureDetails><uuid>40280381-51f0-825b-0152-2273af5a150b</uuid><title>HIV/AIDS: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis</title><shortTitle>CMS52</shortTitle><emeasureid>52</emeasureid><guid>1cdd20de-5de9-4759-8a93-31f1f8baaaa2</guid><version>5.0.000</version><nqfid extension="0405" root="2.16.840.1.113883.3.560.1"/><period calenderYear="true" uuid="40280381-3e93-d1af-013e-a49f8f3f4136"><startDate>00000101</startDate><stopDate>00001231</stopDate></period><steward id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</steward><developers><developer id="2.16.840.1.113883.3.526">American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)</developer><developer id="2.16.840.1.113883.3.464">National Committee for Quality Assurance</developer></developers><endorsement id="2.16.840.1.113883.3.560">National Quality Forum</endorsement><description>Percentage of patients aged 6 weeks and older with a diagnosis of HIV/AIDS who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis</description><copyright>Copyright 2015 National Committee for Quality Assurance (NCQA) and American Medical Association. All Rights Reserved.</copyright><disclaimer>Physician Performance Measures (Measures) and related data specifications have been developed by the American Medical Association (AMA) - convened Physician Consortium for Performance Improvement(R) (PCPI(R)) and the National Committee for Quality Assurance (NCQA). These Measures are not clinical guidelines and do not establish a standard of medical care, and have not been tested for all potential applications. The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain. Commercial uses of the Measures require a license agreement between the user and the AMA, (on behalf of the PCPI) or NCQA. Neither the AMA, PCPI, NCQA nor its members shall be responsible for any use of the Measures.

THE MEASURES AND SPECIFICATIONS ARE PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND.

Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, PCPI, NCQA and its members disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT[R]) or other coding contained in the specifications.

CPT(R) contained in the Measure specifications is copyright 2004-2015 American Medical Association. LOINC(R) copyright 2004-2015 Regenstrief Institute, Inc. This material contains SNOMED Clinical Terms(R) (SNOMED CT[R]) copyright 2004-2015 International Health Terminology Standards Development Organisation. ICD-10 copyright 2015 World Health Organization. All Rights Reserved.

Due to technical limitations, registered trademarks are indicated by (R) or [R] and unregistered trademarks are indicated by (TM) or [TM].</disclaimer><scoring id="PROPOR">Proportion</scoring><types><type id="PROCESS">Process</type></types><componentMeasures/><itemCount/><stratification>None</stratification><riskAdjustment>None</riskAdjustment><aggregation>None</aggregation><rationale>Although advances in the management of HIV and AIDS diseases have been made, Pneumocystis jiroveci pneumonia (PCP) remains an important complication and cause of morbidity.  Without PCP prophylaxis, patients with HIV/AIDS are at increased risk of developing PCP, especially when CD4 cell counts falls to 200 cells/mm3-250 cells/mm3 (Kaplan, 1998; Phair, 1990).  PCP prophylaxis is very effective and has been demonstrated to prolong life.   

Data from Kaiser Permanente suggests that there is a gap in care related to the prescription of PCP prophylaxis for patients with HIV.  According to 2005-2006 data from Kaiser Permanente California (both Northern and Southern), Georgia, and Oregon, only 71% of HIV-infected persons with a CD4&lt;200 cells/mm3 received PCP prophylaxis (personal communication, 2007).</rationale><recommendations>HIV-infected adults and adolescents, including pregnant women and those on ART, should receive chemoprophylaxis against PCP if they have CD4 counts &lt;200 cells/mm3 or a history of oropharyngeal candidiasis. (Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2015)

Chemoprophylaxis is highly effective in preventive PCP.  Prophylaxis is recommended for all HIV-infected children aged &gt;= 6 years who have CD4 T lymphocyte (CD4) cell counts &lt;200 cells/mm3 or CD4 percentage &lt;15%, for children aged 1 to &lt;6 years with CD4 counts &lt;500 cells/mm3 or CD4 percentage &lt;15%, and for all HIV-infected infants aged &lt;12 months regardless of CD4 count or percentage. (Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children, 2013)</recommendations><improvementNotations>A higher score indicates better quality</improvementNotations><references><reference>Kaplan JE, Hanson DL, Navin TR, Jones JL. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus--infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. The Journal of Infectious Diseases. 1998;178:1126-32. </reference><reference>Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. Section accessed December 18, 2015 [p. W-1]</reference><reference>Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed December 18, 2015 [p. B-2]</reference><reference>Personal communication. Michael Horberg, MD, Director, HIV/AIDS Policy, Quality Improvement, Research, The Permanente Federation. 2007 Nov 6.</reference><reference>Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group. NEJM. 1990 Jan 18;322:161-65.</reference></references><definitions>None</definitions><guidance>Denominator 1: The CD4 count below 200 cells/mm3 must occur during the first nine months of the year.

Denominator 2: The CD4 count below 500 cells/mm3 or the CD4 percentage below 15% must occur during the first nine months of the year.

Once all denominators and numerators are calculated, a total rate should be calculated using the sum of the three denominators and the sum of the three numerators.</guidance><transmissionFormat>TBD</transmissionFormat><initialPopDescription>Initial Population 1: All patients aged 6 years and older with a diagnosis of HIV/AIDS and a CD4 count below 200 cells/mm3 who had at least two visits during the measurement year, with at least 90 days in between each visit

Initial Population 2: All patients aged 1-5 years of age with a diagnosis of HIV/AIDS and a CD4 count below 500 cells/mm3 or a CD4 percentage below 15% who had at least two visits during the measurement year, with at least 90 days in between each visit

Initial Population 3: All patients aged 6 weeks to 12 months with a diagnosis of HIV who had at least two visits during the measurement year, with at least 90 days in between each visit</initialPopDescription><denominatorDescription>Equals Initial Population</denominatorDescription><denominatorExclusionsDescription>None</denominatorExclusionsDescription><numeratorDescription>Numerator 1: Patients who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis within 3 months of CD4 count below 200 cells/mm3

Numerator 2: Patients who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis within 3 months of CD4 count below 500 cells/mm3 or a CD4 percentage below 15%

Numerator 3: Patients who were prescribed Pneumocystis jiroveci pneumonia (PCP) prophylaxis at the time of diagnosis of HIV</numeratorDescription><numeratorExclusionsDescription>Not Applicable</numeratorExclusionsDescription><denominatorExceptionsDescription>Denominator Exceptions 1: Patient did not receive PCP prophylaxis because there was a CD4 count above 200 cells/mm3 during the three months after a CD4 count below 200 cells/mm3 

Denominator Exceptions 2: Patient did not receive PCP prophylaxis because there was a CD4 count above 500 cells/mm3 or CD4 percentage above 15% during the three months after a CD4 count below 500 cells/mm3 or CD4 percentage below 15% 

Denominator Exceptions 3: None</denominatorExceptionsDescription><supplementalData>For every patient evaluated by this measure also identify payer, race, ethnicity, and sex.</supplementalData><qualityMeasureSet uuid="89dfc215-d5c3-4c9d-9464-6b81b8329538">Not Applicable</qualityMeasureSet>
<finalizedDate value="201602191743-0600"/>
</measureDetails><supplementalDataElements><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4117" name="Ethnicity"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4115" name="ONC Administrative Sex"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4118" name="Payer"/><elementRef id="40280381-3e93-d1af-013e-a49f8f3d4116" name="Race"/></supplementalDataElements><riskAdjustmentVariables/><subTreeLookUp><subTree displayName="Age GTEq 1 year" qdmVariable="false" uuid="0AA9EB6F-47D1-409A-BBF1-0D7DF24F0D74"><functionalOp displayName="Age&gt;= 1 years at" operatorType="Greater Than or Equal To" quantity="1" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></functionalOp></subTree><subTree displayName="Age GTEq 6 years" qdmVariable="false" uuid="76CBFCEF-72FF-44BC-9785-745BC4881967"><functionalOp displayName="Age&gt;= 6 years at" operatorType="Greater Than or Equal To" quantity="6" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></functionalOp></subTree><subTree displayName="Age LT 6 years" qdmVariable="false" uuid="9E1B4BE9-49AB-46C4-B978-EFEB5615F116"><functionalOp displayName="Age&lt; 6 years at" operatorType="Less Than" quantity="6" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></functionalOp></subTree><subTree displayName="Age LT 1 year" qdmVariable="false" uuid="BC4ED74C-5E08-4E30-88F5-EBD5422F9024"><functionalOp displayName="Age&lt; 1 years at" operatorType="Less Than" quantity="1" type="AGE AT" unit="years"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></functionalOp></subTree><subTree displayName="HIVvisit" qdmVariable="true" uuid="0A1575F7-68AC-4C37-AC1B-A86557A13F6F"><relationalOp displayName="During" type="DURING"><setOp displayName="Union" type="union"><elementRef displayName="Office Visit : Encounter, Performed" id="53ac9eca-bdc8-4a25-bb93-f88e7282c0b0" type="qdm"/><elementRef displayName="Face-to-Face Interaction : Encounter, Performed" id="7ce4263a-8416-478c-ab22-50f81a2c0760" type="qdm"/><elementRef displayName="Preventive Care Services - Established Office Visit, 18 and Up : Encounter, Performed" id="b8283288-b7d3-4467-9453-d5cf3c016769" type="qdm"/><elementRef displayName="Preventive Care Services-Initial Office Visit, 18 and Up : Encounter, Performed" id="2f8f8431-164b-4079-8f5c-1952a213b909" type="qdm"/><elementRef displayName="Preventive Care - Established Office Visit, 0 to 17 : Encounter, Performed" id="b9e77540-5948-4885-b507-9706cc48a329" type="qdm"/><elementRef displayName="Preventive Care- Initial Office Visit, 0 to 17 : Encounter, Performed" id="9ad90d65-1eef-40d0-ac30-9b60e895e5f7" type="qdm"/><elementRef displayName="Outpatient Consultation : Encounter, Performed" id="63ed2cc3-f71b-47dd-a318-e57799a404b3" type="qdm"/></setOp><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="HIV Dx SBE MP" qdmVariable="false" uuid="EDFF6B73-AB9E-4914-908D-49039D84C7B9"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="HIV 1 : Diagnosis" id="abf5cb1c-6014-4c16-9991-f0af2322bf3d" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="CD4count OccA" qdmVariable="false" uuid="7BDCDE07-4D74-499C-8FD3-49CAC305112B"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"><attribute attrUUID="accdcfd7-f8d7-4eca-9657-aaec0d4ec8a1" comparisonValue="200" mode="Less Than" name="result" unit="per mm3"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="CD4count" qdmVariable="true" uuid="6B595C40-39F5-4ABB-A2A7-FD6486D972E3"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="CD4+ Count : Laboratory Test, Performed" id="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" type="qdm"><attribute attrUUID="682abe28-f49e-4c3b-bc81-9f50e86f4986" comparisonValue="500" mode="Less Than" name="result" unit="per mm3"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="Occurrence A of $CD4count" instance="A" instanceOf="6B595C40-39F5-4ABB-A2A7-FD6486D972E3" qdmVariable="true" uuid="72AEE716-5D30-452D-A174-418186137764"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="CD4+ Count : Laboratory Test, Performed" id="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" type="qdm"><attribute attrUUID="42C8C9A0-7976-435D-86C3-FE5C5A05AF7B" comparisonValue="500" mode="Less Than" name="result" unit="per mm3"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="PCP LT 1 day SACWS Occ A HIV" qdmVariable="false" uuid="9C1879E1-F2A0-415C-9FBA-87F4197FDC23"><relationalOp displayName="&lt; 1 days Starts After Or Concurrent With Start Of" operatorType="Less Than" quantity="1" type="SASORSCW" unit="days"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of HIV 1 : Diagnosis" id="83ff2822-843f-456c-8945-6feb45c5651a" type="qdm"/></relationalOp></subTree><subTree displayName="PCP LT 3 Mo SAE CD4count OccA" qdmVariable="false" uuid="72527E85-E903-4F00-A098-05994E13C85A"><relationalOp displayName="&lt; 3 months Starts After End Of" operatorType="Less Than" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp></subTree><subTree displayName="Dapsone n Pyrimetharmine LT 3 Mo SAE CD4count OccA" qdmVariable="false" uuid="1E172826-3348-4448-AD9C-9673592A0826"><relationalOp displayName="&lt; 3 months Starts After End Of" operatorType="Less Than" quantity="3" type="SAE" unit="months"><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp></subTree><subTree displayName="Dapsone n Pyrimetharmine LT 1 Day SBCWS Leucovorin OccA" qdmVariable="false" uuid="443EE884-3B2B-45ED-B958-BB675242E136"><relationalOp displayName="&lt; 1 days Starts Before Or Concurrent With Start Of" operatorType="Less Than" quantity="1" type="SBSORSCW" unit="days"><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/></relationalOp></subTree><subTree displayName="Leucovorin LT 1 Day SBCWS Dapsone n PyrimetharmineOccA" qdmVariable="false" uuid="94775742-8FDF-4941-9CD0-9F91609F6D50"><relationalOp displayName="&lt; 1 days Starts Before Or Concurrent With Start Of" operatorType="Less Than" quantity="1" type="SBSORSCW" unit="days"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of Dapsone and pyrimethamine : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" type="qdm"/></relationalOp></subTree><subTree displayName="Dapsone n pyrimethamine OR Leucovorin" qdmVariable="false" uuid="66EEE0D1-023F-4CB3-8188-9B7C0F3CB365"><setOp displayName="Union" type="union"><subTreeRef displayName="Dapsone n Pyrimetharmine LT 1 Day SBCWS Leucovorin OccA" id="443EE884-3B2B-45ED-B958-BB675242E136" type="subTree"/><subTreeRef displayName="Leucovorin LT 1 Day SBCWS Dapsone n PyrimetharmineOccA" id="94775742-8FDF-4941-9CD0-9F91609F6D50" type="subTree"/></setOp></subTree><subTree displayName="Leucovorin LT 3 Mo SAE CD4count OccA" qdmVariable="false" uuid="AA69EE3F-50E2-4F38-9266-DAC446644FC1"><relationalOp displayName="&lt; 3 months Starts After End Of" operatorType="Less Than" quantity="3" type="SAE" unit="months"><elementRef displayName="Occurrence A of Leucovorin : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" type="qdm"/><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp></subTree><subTree displayName="CD4count GTEq 200" qdmVariable="false" uuid="9B568BBF-AEA5-46AA-BB2D-371C14C554DB"><relationalOp displayName="&lt; 3 months Ends After End Of" operatorType="Less Than" quantity="3" type="EAE" unit="months"><elementRef displayName="CD4+ Count : Laboratory Test, Performed" id="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" type="qdm"><attribute attrUUID="c599bab3-8326-42a8-b646-7491fb3fcc1f" comparisonValue="200" mode="Greater Than Or Equal To" name="result" unit="per mm3"/></elementRef><elementRef displayName="Occurrence A of CD4+ Count : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" type="qdm"/></relationalOp></subTree><subTree displayName="Age GTEq 6 weeks" qdmVariable="false" uuid="3D445AAE-D699-4EA5-8ABE-E944C8046E57"><functionalOp displayName="Age&gt;= 6 weeks at" operatorType="Greater Than or Equal To" quantity="6" type="AGE AT" unit="weeks"><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></functionalOp></subTree><subTree displayName="First HIV Dx SBE MP" qdmVariable="false" uuid="69D55F2A-F5A3-4CCF-A37E-66773B61B063"><functionalOp displayName="First" type="FIRST"><relationalOp displayName="Starts Before End Of" type="SBE"><elementRef displayName="Occurrence A of HIV 1 : Diagnosis" id="83ff2822-843f-456c-8945-6feb45c5651a" type="qdm"/><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></functionalOp></subTree><subTree displayName="HIVvisit SAE GTEq 90 days HIVvisit" qdmVariable="false" uuid="77554418-855D-4A6D-9B59-FDAF5BE7AB60"><relationalOp displayName="&gt;= 90 days Starts After End Of" operatorType="Greater Than or Equal To" quantity="90" type="SAE" unit="days"><subTreeRef displayName="HIVvisit" id="0A1575F7-68AC-4C37-AC1B-A86557A13F6F" type="subTree"/><subTreeRef displayName="HIVvisit" id="0A1575F7-68AC-4C37-AC1B-A86557A13F6F" type="subTree"/></relationalOp></subTree><subTree displayName="CD4percentage" qdmVariable="true" uuid="4A6245B2-2296-408D-909C-8FE88A8A55ED"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="CD4+ Percentage : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"><attribute attrUUID="d949aba4-1ad3-4d87-853f-ca096a8dac9d" comparisonValue="15" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="Occurrence A of $CD4percentage" instance="A" instanceOf="4A6245B2-2296-408D-909C-8FE88A8A55ED" qdmVariable="true" uuid="AE731282-011C-47C0-9490-325E2A8B61E0"><relationalOp displayName="&lt; 9 months Ends After Start Of" operatorType="Less Than" quantity="9" type="EAS" unit="months"><elementRef displayName="CD4+ Percentage : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"><attribute attrUUID="6E761C58-7AB2-4828-9BD6-B31EA8212058" comparisonValue="15" mode="Less Than" name="result" unit="%"/></elementRef><elementRef displayName="Measurement Period : Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" type="qdm"/></relationalOp></subTree><subTree displayName="CD4count GTEq 500 OR CD4percentage GTEq 15" qdmVariable="false" uuid="F119C917-B942-4704-BB8B-91C2706368C2"><setOp displayName="Union" type="union"><relationalOp displayName="&lt; 3 months Ends After End Of" operatorType="Less Than" quantity="3" type="EAE" unit="months"><elementRef displayName="CD4+ Count : Laboratory Test, Performed" id="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" type="qdm"><attribute attrUUID="0a434ca7-a369-4813-a060-670eba8ced81" comparisonValue="500" mode="Greater Than Or Equal To" name="result" unit="per mm3"/></elementRef><subTreeRef displayName="Occurrence A of CD4count" id="72AEE716-5D30-452D-A174-418186137764" type="subTree"/></relationalOp><relationalOp displayName="&lt; 3 months Ends After End Of" operatorType="Less Than" quantity="3" type="EAE" unit="months"><elementRef displayName="CD4+ Percentage : Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3e412a" type="qdm"><attribute attrUUID="eb38f607-4992-4d9a-b019-7ef49563b979" comparisonValue="15" mode="Greater Than Or Equal To" name="result" unit="%"/></elementRef><subTreeRef displayName="Occurrence A of CD4percentage" id="AE731282-011C-47C0-9490-325E2A8B61E0" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="PCP LT 3 Mo SAE CD4count or CD4percentage OccA" qdmVariable="false" uuid="4D19EA16-8197-45A8-883C-E5838CEC7FE4"><setOp displayName="Union" type="union"><relationalOp displayName="&lt; 3 months Starts After End Of" operatorType="Less Than" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><subTreeRef displayName="Occurrence A of CD4count" id="72AEE716-5D30-452D-A174-418186137764" type="subTree"/></relationalOp><relationalOp displayName="&lt; 3 months Starts After End Of" operatorType="Less Than" quantity="3" type="SAE" unit="months"><elementRef displayName="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis : Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" type="qdm"/><subTreeRef displayName="Occurrence A of CD4percentage" id="AE731282-011C-47C0-9490-325E2A8B61E0" type="subTree"/></relationalOp></setOp></subTree><subTree displayName="CD4count or CD4percentage OccA" qdmVariable="false" uuid="D2C9568D-6A78-4D3B-AFA2-9906E7616A05"><setOp displayName="Union" type="union"><subTreeRef displayName="Occurrence A of CD4count" id="72AEE716-5D30-452D-A174-418186137764" type="subTree"/><subTreeRef displayName="Occurrence A of CD4percentage" id="AE731282-011C-47C0-9490-325E2A8B61E0" type="subTree"/></setOp></subTree></subTreeLookUp><measureGrouping><group sequence="1"><clause displayName="Initial Population 1" type="initialPopulation" uuid="E681DBF8-F827-4586-B3E0-178FF19EC3A2"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTEq 6 years" id="76CBFCEF-72FF-44BC-9785-745BC4881967" type="subTree"/><subTreeRef displayName="HIV Dx SBE MP" id="EDFF6B73-AB9E-4914-908D-49039D84C7B9" type="subTree"/><subTreeRef displayName="HIVvisit SAE GTEq 90 days HIVvisit" id="77554418-855D-4A6D-9B59-FDAF5BE7AB60" type="subTree"/><subTreeRef displayName="CD4count OccA" id="7BDCDE07-4D74-499C-8FD3-49CAC305112B" type="subTree"/></logicalOp></clause><clause displayName="Denominator 1" type="denominator" uuid="04BF53CE-6993-4EA2-BFE5-66E36172B388"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 1" type="denominatorExceptions" uuid="58347456-D1F3-4BBB-9B35-5D42825A0AB3"><logicalOp displayName="OR" type="or"><subTreeRef displayName="CD4count GTEq 200" id="9B568BBF-AEA5-46AA-BB2D-371C14C554DB" type="subTree"/></logicalOp></clause><clause displayName="Numerator 1" type="numerator" uuid="631C0B49-83F4-4A54-96C4-7E0766B2407C"><logicalOp displayName="AND" type="and"><logicalOp displayName="OR" type="or"><subTreeRef displayName="PCP LT 3 Mo SAE CD4count OccA" id="72527E85-E903-4F00-A098-05994E13C85A" type="subTree"/><logicalOp displayName="AND" type="and"><subTreeRef displayName="Dapsone n Pyrimetharmine LT 3 Mo SAE CD4count OccA" id="1E172826-3348-4448-AD9C-9673592A0826" type="subTree"/><subTreeRef displayName="Leucovorin LT 3 Mo SAE CD4count OccA" id="AA69EE3F-50E2-4F38-9266-DAC446644FC1" type="subTree"/><subTreeRef displayName="Dapsone n pyrimethamine OR Leucovorin" id="66EEE0D1-023F-4CB3-8188-9B7C0F3CB365" type="subTree"/></logicalOp></logicalOp></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="4c42d3ad-5ad4-4e97-ac7d-81c9758fbead"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="9656a21e-6580-4881-ba83-9764673dcd1f"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="cc396423-69cc-41f2-a166-613e6143b5a7"/></group><group sequence="2"><clause displayName="Initial Population 2" type="initialPopulation" uuid="AAC578DB-1900-43BD-BBBF-50014A5457E5"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTEq 1 year" id="0AA9EB6F-47D1-409A-BBF1-0D7DF24F0D74" type="subTree"/><subTreeRef displayName="Age LT 6 years" id="9E1B4BE9-49AB-46C4-B978-EFEB5615F116" type="subTree"/><subTreeRef displayName="HIV Dx SBE MP" id="EDFF6B73-AB9E-4914-908D-49039D84C7B9" type="subTree"/><subTreeRef displayName="HIVvisit SAE GTEq 90 days HIVvisit" id="77554418-855D-4A6D-9B59-FDAF5BE7AB60" type="subTree"/><subTreeRef displayName="CD4count or CD4percentage OccA" id="D2C9568D-6A78-4D3B-AFA2-9906E7616A05" type="subTree"/></logicalOp></clause><clause displayName="Denominator 2" type="denominator" uuid="1574973E-EB52-40C7-9709-25ABEDBA99A3"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Denominator Exceptions 2" type="denominatorExceptions" uuid="B7CCA1A6-F352-4A23-BC89-6FE9B60DC0C6"><logicalOp displayName="OR" type="or"><subTreeRef displayName="CD4count GTEq 500 OR CD4percentage GTEq 15" id="F119C917-B942-4704-BB8B-91C2706368C2" type="subTree"/></logicalOp></clause><clause displayName="Numerator 2" type="numerator" uuid="5B7AC4EC-547A-47E5-AC5E-618401175511"><logicalOp displayName="AND" type="and"><subTreeRef displayName="PCP LT 3 Mo SAE CD4count or CD4percentage OccA" id="4D19EA16-8197-45A8-883C-E5838CEC7FE4" type="subTree"/></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="659d5fba-93ed-4b1f-bd17-233362e37e58"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="8912bc80-8098-4e37-96f7-a38438b53fdf"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="904ead56-333d-4ce1-ad57-4f446b21cfe5"/></group><group sequence="3"><clause displayName="Initial Population 3" type="initialPopulation" uuid="AF36C4A9-8BD9-4E21-838D-A47A1845EB90"><logicalOp displayName="AND" type="and"><subTreeRef displayName="Age GTEq 6 weeks" id="3D445AAE-D699-4EA5-8ABE-E944C8046E57" type="subTree"/><subTreeRef displayName="Age LT 1 year" id="BC4ED74C-5E08-4E30-88F5-EBD5422F9024" type="subTree"/><subTreeRef displayName="First HIV Dx SBE MP" id="69D55F2A-F5A3-4CCF-A37E-66773B61B063" type="subTree"/><subTreeRef displayName="HIVvisit SAE GTEq 90 days HIVvisit" id="77554418-855D-4A6D-9B59-FDAF5BE7AB60" type="subTree"/></logicalOp></clause><clause displayName="Denominator 3" type="denominator" uuid="B95BC0D3-572E-462B-BAA2-46CD33A865CD"><logicalOp displayName="AND" type="and"/></clause><clause displayName="Numerator 3" type="numerator" uuid="86F74F07-D593-44F6-AA12-405966400963"><logicalOp displayName="AND" type="and"><subTreeRef displayName="PCP LT 1 day SACWS Occ A HIV" id="9C1879E1-F2A0-415C-9FBA-87F4197FDC23" type="subTree"/></logicalOp></clause><clause displayName="denominatorExclusions" type="denominatorExclusions" uuid="8d54df2e-8a7e-49e3-a99a-0132f5139b7c"><logicalOp displayName="AND" type="and"/></clause><clause displayName="numeratorExclusions" type="numeratorExclusions" uuid="36069000-75a6-498c-a619-906324b5e520"><logicalOp displayName="AND" type="and"/></clause><clause displayName="denominatorExceptions" type="denominatorExceptions" uuid="28ee691d-8155-41fe-8c20-12a5d2e1fb75"><logicalOp displayName="AND" type="and"/></clause><clause displayName="stratum" type="stratum" uuid="801f7faa-ef93-44b6-b4fc-23656c922fd6"/></group></measureGrouping><elementLookUp><qdm datatype="Patient Characteristic Birthdate" id="6ae5b3b4-f397-458e-90e9-6f6fdc20b5f6" name="Birthdate" oid="21112-8" suppDataElement="false" taxonomy="SNOMED-CT" uuid="6ae5b3b4-f397-458e-90e9-6f6fdc20b5f6" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3d411f" instance="Occurrence A" name="CD4+ Count" oid="2.16.840.1.113883.3.464.1003.121.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d411f" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Laboratory Test, Performed" id="40280381-3e93-d1af-013e-a49f8f3e412a" name="CD4+ Percentage" oid="2.16.840.1.113883.3.464.1003.121.12.1005" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3e412a" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3f413b" instance="Occurrence A" name="Dapsone and pyrimethamine" oid="2.16.840.1.113883.3.464.1003.196.12.1202" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3f413b" version="1"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Ethnicity" id="40280381-3e93-d1af-013e-a49f8f3d4117" name="Ethnicity" oid="2.16.840.1.114222.4.11.837" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-a49f8f3d4117" version="1"/><qdm datatype="Patient Characteristic Expired" id="66ddff3e-18bc-42bf-904d-41affcc5c936" name="Expired" oid="419099009" suppDataElement="false" taxonomy="SNOMED-CT" uuid="66ddff3e-18bc-42bf-904d-41affcc5c936" version="1.0"/><qdm datatype="Encounter, Performed" id="7ce4263a-8416-478c-ab22-50f81a2c0760" name="Face-to-Face Interaction" oid="2.16.840.1.113883.3.464.1003.101.12.1048" suppDataElement="false" taxonomy="Grouping" uuid="7ce4263a-8416-478c-ab22-50f81a2c0760" version="1.0"/><qdm datatype="Diagnosis" id="83ff2822-843f-456c-8945-6feb45c5651a" instance="Occurrence A" name="HIV 1" oid="2.16.840.1.113883.3.464.1003.120.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="83ff2822-843f-456c-8945-6feb45c5651a" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3e4127" instance="Occurrence A" name="Leucovorin" oid="2.16.840.1.113883.3.464.1003.196.12.1205" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3e4127" version="1"/><qdm codeSystemName="National Quality Forum" datatype="Timing Element" id="40280381-3e93-d1af-013e-a49f8f3f4136" name="Measurement Period" oid="2.16.840.1.113883.3.67.1.101.1.53" suppDataElement="false" taxonomy="NQF" uuid="40280381-3e93-d1af-013e-a49f8f3f4136" version="1"/><qdm datatype="Encounter, Performed" id="53ac9eca-bdc8-4a25-bb93-f88e7282c0b0" name="Office Visit" oid="2.16.840.1.113883.3.464.1003.101.12.1001" suppDataElement="false" taxonomy="Grouping" uuid="53ac9eca-bdc8-4a25-bb93-f88e7282c0b0" version="1.0"/><qdm codeSystemName="National Library of Medicine" datatype="Patient Characteristic Sex" id="40280381-3e93-d1af-013e-a49f8f3d4115" name="ONC Administrative Sex" oid="2.16.840.1.113762.1.4.1" suppDataElement="true" taxonomy="AdministrativeGender" uuid="40280381-3e93-d1af-013e-a49f8f3d4115" version="1"/><qdm datatype="Encounter, Performed" id="63ed2cc3-f71b-47dd-a318-e57799a404b3" name="Outpatient Consultation" oid="2.16.840.1.113883.3.464.1003.101.12.1008" suppDataElement="false" taxonomy="Grouping" uuid="63ed2cc3-f71b-47dd-a318-e57799a404b3" version="1.0"/><qdm codeSystemName="PHDSC" datatype="Patient Characteristic Payer" id="40280381-3e93-d1af-013e-a49f8f3d4118" name="Payer" oid="2.16.840.1.114222.4.11.3591" suppDataElement="true" taxonomy="SOP" uuid="40280381-3e93-d1af-013e-a49f8f3d4118" version="1"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="40280381-3e93-d1af-013e-a49f8f3d4122" name="Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis" oid="2.16.840.1.113883.3.464.1003.196.12.1076" suppDataElement="false" taxonomy="Grouping" uuid="40280381-3e93-d1af-013e-a49f8f3d4122" version="1"/><qdm datatype="Encounter, Performed" id="b9e77540-5948-4885-b507-9706cc48a329" name="Preventive Care - Established Office Visit, 0 to 17" oid="2.16.840.1.113883.3.464.1003.101.12.1024" suppDataElement="false" taxonomy="Grouping" uuid="b9e77540-5948-4885-b507-9706cc48a329" version="1.0"/><qdm datatype="Encounter, Performed" id="b8283288-b7d3-4467-9453-d5cf3c016769" name="Preventive Care Services - Established Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1025" suppDataElement="false" taxonomy="Grouping" uuid="b8283288-b7d3-4467-9453-d5cf3c016769" version="1.0"/><qdm datatype="Encounter, Performed" id="2f8f8431-164b-4079-8f5c-1952a213b909" name="Preventive Care Services-Initial Office Visit, 18 and Up" oid="2.16.840.1.113883.3.464.1003.101.12.1023" suppDataElement="false" taxonomy="Grouping" uuid="2f8f8431-164b-4079-8f5c-1952a213b909" version="1.0"/><qdm datatype="Encounter, Performed" id="9ad90d65-1eef-40d0-ac30-9b60e895e5f7" name="Preventive Care- Initial Office Visit, 0 to 17" oid="2.16.840.1.113883.3.464.1003.101.12.1022" suppDataElement="false" taxonomy="Grouping" uuid="9ad90d65-1eef-40d0-ac30-9b60e895e5f7" version="1.0"/><qdm codeSystemName="CDC NCHS" datatype="Patient Characteristic Race" id="40280381-3e93-d1af-013e-a49f8f3d4116" name="Race" oid="2.16.840.1.114222.4.11.836" suppDataElement="true" taxonomy="CDCREC" uuid="40280381-3e93-d1af-013e-a49f8f3d4116" version="1"/><qdm datatype="Laboratory Test, Performed" id="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" name="CD4+ Count" oid="2.16.840.1.113883.3.464.1003.121.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="fe396d84-5c2c-448e-84b9-e6c4b7064c0d" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="39534682-4165-4b50-9182-f8a980fda0f5" name="Dapsone and pyrimethamine" oid="2.16.840.1.113883.3.464.1003.196.12.1202" suppDataElement="false" taxonomy="Grouping" uuid="39534682-4165-4b50-9182-f8a980fda0f5" version="1"/><qdm datatype="Diagnosis" id="abf5cb1c-6014-4c16-9991-f0af2322bf3d" name="HIV 1" oid="2.16.840.1.113883.3.464.1003.120.12.1004" suppDataElement="false" taxonomy="Grouping" uuid="abf5cb1c-6014-4c16-9991-f0af2322bf3d" version="1.0"/><qdm codeSystemName="National Committee for Quality Assurance" datatype="Medication, Order" id="0a8ca0e5-aac5-4abd-b5f7-ae1fc81bec8c" name="Leucovorin" oid="2.16.840.1.113883.3.464.1003.196.12.1205" suppDataElement="false" taxonomy="Grouping" uuid="0a8ca0e5-aac5-4abd-b5f7-ae1fc81bec8c" version="1"/></elementLookUp></measure>